Table of Contents

Table II
Summary of Sites by Stage, Race, and Sex
Indiana, 1996
Site

Number* of Cases

Percent of Total Cases SEER** Summary Stage at Diagnosis Race Sex
In Situ Local Regional Distant Unstaged White Black Other Male Female
All sites 26,180 100.0% 2,050 10,752 6,120 4,973 2,285 24,155 1,772 253 12,401 13,779
Oral cavity and pharynx 610 2.3% 19 259 271 29 32 548 56 6 402 208
Lip 55 0.2% 6 45 1 0 3 54 0 1 43 12
Tongue 130 0.5% 4 51 63 4 8 115 14 1 86 44
Major salivary glands 67 0.3% 0 40 21 2 4 65 2 0 32 35
Floor of mouth 45 0.2% 2 22 16 2 3 41 3 1 33 12
Gum and other mouth 127 0.5% 4 58 51 9 5 114 12 1 69 58
Nasopharynx 32 0.1% 0 7 21 3 1 29 2 1 23 9
Tonsil 63 0.2% 2 15 42 2 2 53 10 0 48 15
Oropharynx 18 0.1% 0 4 13 1 0 13 5 0 14 4
Hypopharynx 51 0.2% 1 12 30 5 3 44 6 1 41 10
Pharynx and other oral cavity 22 0.1% 0 5 13 1 3 20 2 0 13 9
Digestive system 4,807 18.4% 253 1,321 1,927 973 333 4,423 359 25 2,501 2,306
Esophagus 238 0.9% 2 62 73 67 34 219 17 2 190 48
Stomach 295 1.1% 3 55 118 84 35 264 27 4 163 132
Small intestine 74 0.3% 2 20 32 15 5 63 11 0 35 39
Colon excluding rectum 2,414 9.2% 165 734 1,034 392 89 2,220 187 7 1,175 1,239
Rectum and rectosigmoid 887 3.4% 70 289 366 117 45 829 52 6 496 391
Anus, anal canal, and anorectum 60 0.2% 5 29 15 6 5 59 1 0 19 41
Liver and intrahepatic bile duct 159 0.6% 0 55 34 33 37 147 9 3 98 61
Gallbladder 55 0.2% 3 14 20 15 3 53 2 0 15 40
Other biliary 69 0.3% 0 14 31 10 14 66 3 0 44 25
Pancreas 492 1.9% 3 38 196 206 49 445 44 3 243 249
Retroperitoneum 24 0.1% 0 7 4 6 7 23 1 0 12 12
Peritoneum 29 0.1% 0 2 4 17 6 24 5 0 5 24
Other digestive organs 11 0.0% 0 2 0 5 4 11 0 0 6 5
Respiratory system 4,554 17.4% 20 1,100 1,293 1,682 459 4,228 303 23 2,846 1,708
Nasal cavity, ear, and sinuses 26 0.1% 0 7 13 6 0 25 1 0 17 9
Larynx 329 1.3% 17 197 82 14 19 304 25 0 261 68
Lung and bronchus 4,154 15.9% 3 890 1,185 1,655 421 3,857 274 23 2,536 1,618
Trachea, pleura, and other respiratory organs 45 0.2% 0 6 13 7 19 42 3 0 32 13
Bones and joints 42 0.2% 0 17 12 4 9 37 5 0 24 18
Soft tissue (including heart) 142 0.5% 0 77 27 24 14 128 12 2 94 48
Skin (including basal and squamous) 886 3.4% 147 589 42 57 51 841 15 30 506 380
Melanoma of the skin 767 2.9% 145 522 36 21 43 738 3 26 433 334
Other non-epithelial skin cancers 119 0.5% 2 67 6 36 8 103 12 4 73 46
Breast 4,372 16.7% 583 2,379 1,129 175 106 4,062 269 41 23 4,349
Female genital system 2,471 9.4% 763 977 301 340 90 2,281 160 30 0 2,471
Cervix uteri 918 3.5% 621 177 86 21 13 817 79 22 0 918
Corpus uteri 841 3.2% 31 607 116 54 33 797 41 3 0 841
Uterus, NOS 14 0.1% 0 4 4 2 4 11 2 1 0 14
Ovary 471 1.8% 0 124 69 249 29 451 20 0 0 471
Vagina 30 0.1% 10 9 5 3 3 27 3 0 0 30
Vulva 184 0.7% 101 52 19 5 7 167 13 4 0 184
Other female genital organs 13 0.0% 0 4 2 6 1 11 2 0 0 13
Male genital system 3,023 11.5% 18 2,100 428 220 257 2,669 302 52 3,023 0
Prostate gland 2,849 10.9% 10 1,992 400 197 250 2,503 299 47 2,849 0
Testis 137 0.5% 0 85 24 22 6 133 0 4 137 0
Penis 33 0.1% 8 19 4 1 1 29 3 1 33 0
Other male genital organs 4 0.0% 0 4 0 0 0 4 0 0 4 0
Urinary system 1,940 7.4% 247 1,131 271 188 103 1,838 92 10 1,322 618
Urinary bladder 1,150 4.4% 233 695 124 32 66 1,107 36 7 832 318
Kidney and renal pelvis 729 2.8% 7 398 138 152 34 673 53 3 453 276
Ureter 42 0.2% 6 29 3 2 2 39 3 0 26 16
Other urinary organs 19 0.1% 1 9 6 2 1 19 0 0 11 8
Eye and orbit 40 0.2% 0 32 2 1 5 36 1 3 16 24
Brain and other nervous system 377 1.4% 0 244 75 8 50 356 19 2 213 164
Brain 353 1.3% 0 232 75 5 41 336 15 2 206 147
Other nervous system 24 0.1% 0 12 0 3 9 20 4 0 7 17
Endocrine system 307 1.2% 0 199 72 23 13 287 14 6 83 224
Thyroid gland 277 1.1% 0 188 64 15 10 260 11 6 67 210
Other endocrine (including thymus) 30 0.1% 0 11 8 8 3 27 3 0 16 14
Lymphoma 1,181 4.5% 0 318 269 428 166 1,108 62 11 607 574
Hodgkin’s disease 152 0.6% 0 31 60 37 24 143 8 1 85 67
Non-Hodgkin’s lymphoma 1,029 3.9% 0 287 209 391 142 965 54 10 522 507
Multiple myeloma 244 0.9% 0 6 0 237 1 212 31 1 131 113
Leukemia 571 2.2% 0 0 0 571 0 532 32 7 316 255
Acute lymphocytic 69 0.3% 0 0 0 69 0 65 3 1 34 35
Chronic lymphocytic 159 0.6% 0 0 0 159 0 148 8 3 93 66
Acute myeloid 181 0.7% 0 0 0 181 0 169 11 1 91 90
Chronic myeloid 79 0.3% 0 0 0 79 0 73 4 2 47 32
Other leukemias 83 0.3% 0 0 0 83 0 77 6 0 51 32
Other, ill-defined, and unknown sites 613 2.3% 0 3 1 13 596 569 40 4 294 319

   * Please note that these totals will not match those in Table I - 0 as these numbers include all in situ cases as well as basal and squamous skin cell cancers, and cases of unspecified age.
** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
_________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table of Contents